Hospital claims it was ‘drastically’ overcharged by pharma in 340B program

Taking stock of the drug industry, from the lab to the medicine chest

February 15, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Hospital claims it was 'drastically' overcharged by pharma in a federal drug discount program The allegations turn on the complicated, behind-the-scenes calculations used to provide medicines to what is known as the 340B program. By Ed Silverman STAT+ | FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound The FDA is concerned these websites that sell the underlying chemicals in Wegovy and Zepbound are marketing unapproved products to consumers. By Elaine Chen Covid-19 vaccine confidence soured by officials' messaging, Republicans argue A House hearing on vaccine safety claims sought to pierce through Americans' falling confidence in routine shots and the spread of Covid-19 misinformation. By Sarah Owermohle Listen: Pharma goes to Washington, Alnylam's future, & Gilead's dealmaking The pharma industry, in court and in Congress, is working to water down legislation that will let Medicare negotiate certain drug prices. By Damian Garde and Allison DeAngelis and Adam Feuerstein Abortion pills offered via telehealth as safe as in-person medication abortions, study finds Study finds no increase in adverse reactions with telehealth abortions. Combination of mifepristone, misoprostol shown to be safe, effective. By Annalisa Merelli STAT+ | Gaming Amylyx stock reactions to the next ALS drug test, and a chat with CRISPR's CEO about a new investor Adam Feuerstein games out upcoming results on the supplement TUDCA for ALS patients, and chats with CRISPR Therapeutics' CEO. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser